MIF
BIIB icon

Mediolanum International Funds’s Biogen BIIB Stock Holding History

Mediolanum International Funds’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
6,010
-44
-0.7% -$8.42K 0.01% 395
2026
Q1 		$1.14M Buy
+6,054
New +$1.12M 0.01% 384
2024
Q4 		– Sell
-4,893
Closed -$951K – 439
2024
Q3 		$951K Sell
4,893
-241
-5% -$50.4K 0.01% 386
2024
Q2 		$1.1M Sell
5,134
-25,144
-83% -$5.46M 0.02% 340
2024
Q1 		$6.55M Buy
+30,278
New +$7.09M 0.11% 197

Other funds holding BIIB

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Mediolanum International Funds's BIIB Position: Q2 2026 in Review

Mediolanum International Funds reduced its Biogen (BIIB) stake by 0.73% in Q2 2026, selling an estimated $8.42K and leaving 6,010 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #395.

Mediolanum International Funds first reported a position in BIIB in Q1 2024 and has held it in 5 quarters since. The position peaked at $6.55M in Q1 2024. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Mediolanum International Funds held 6,010 shares of Biogen worth $1.3M as of Q2 2026.
  • Mediolanum International Funds sold 44 Biogen shares in Q2 2026, an estimated $8.42K.
  • Biogen made up 0.01% of Mediolanum International Funds's portfolio in Q2 2026, its #395 holding.
  • Mediolanum International Funds first reported a position in Biogen in Q1 2024 and has held it in 5 quarters since.
  • Mediolanum International Funds's Biogen position peaked at $6.55M in Q1 2024.
  • 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.